Skip to search formSkip to main contentSkip to account menu

disorder control (procedure)

Known as: disorder control, control disease, disease control 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Phonosurgical resection using submucosal infusion technique for precancerous laryngeal leukoplakia
This study was designed to assess the feasibility of the submucosal infusion technique combined with microflap dissection as a… 
Review
2017
Review
2017
Differential pharmacology and clinical utility of sonidegib in advanced basal cell carcinoma
Patients suffering from advanced basal cell carcinoma (BCC) have very limited treatment options. Sonidegib selectively inhibits… 
Review
2014
Review
2014
Dendritic Cell Therapy in an Allogeneic-Hematopoietic Cell Transplantation Setting: An Effective Strategy toward Better Disease Control?
Hematopoietic cell transplantation (HCT) is a last treatment resort and only potentially curative treatment option for several… 
2014
2014
Intensity-modulated pelvic radiation therapy and simultaneous integrated boost to the prostate area in patients with high-risk prostate cancer: a preliminary report of disease control
The aim of the study was to report the clinical results in patients with high‐risk prostate cancer treated with pelvic intensity… 
Review
2013
Review
2013
Clinical significance of erlotinib monotherapy for gefitinib-resistant non-small cell lung cancer with EGFR mutations.
BACKGROUND The efficacy of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) erlotinib is difficult to… 
2012
2012
Effectiveness of Erlotinib in Advanced Non-Small Cell Lung Cancer in Cases of Gefitinib Resistance after Treatment of More Than 6 Months
Background: There have been reports on the use of erlotinib in non-small cell lung cancer (NSCLC) patients after gefitinib… 
2011
2011
Abstract LB-88: Gene expression signatures predictive of clinical outcome and tumor mutations in refractory NSCLC patients (pts) in the BATTLE trial (Biomarker-integrated Approaches of Targeted…
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Background : There are currently no established markers… 
2007
2007
IFCT0401-bio trial: Predictive biological markers for disease control (DC) of patients with non-resectable, adenocarcinoma with bronchioloalveolar carcinoma features (ADC-BAC) treated with gefitinib
7653 Background: A French prospective multicentric phase II trial (IFCT0401) evaluated gefitinib as first-line treatment in non… 
2006
2006
Salvage treatment with single-agent capecitabine in patients with heavily pretreated advanced colorectal cancer.
BACKGROUND Refractory and/or relapsing advanced colorectal cancer (ACRC) requires frequent and prolonged hospitalisations, with a… 
1999
1999
Increased HLA-DR and CD44 antigen expression in the gut: evidence of extraarticular immunological activity in rheumatoid arthritis.
OBJECTIVE To examine the gastrointestinal (GI) immune system in rheumatoid arthritis (RA) for evidence of activation. METHODS… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)